Search Articles
VENTURA, Calif. – Amgen was fined $762 million for promoting Aranesp, Enbrel and Neulasta for off-label uses and paying kickbacks, and shareholders are not happy about it, in Ventura County Court.
Categories /
Uncategorized
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.